Restenosis after coronary angioplasty - A review of the pathogenesis and strategies for prevention

dc.contributor.authorDavids, MR
dc.contributor.authorDoubell A.F.
dc.date.accessioned2011-05-15T16:15:59Z
dc.date.available2011-05-15T16:15:59Z
dc.date.issued1995
dc.description.abstract[No abstract available]
dc.description.versionReview
dc.identifier.citationCardiovascular Journal of Southern Africa
dc.identifier.citation6
dc.identifier.citation3
dc.identifier.issn10159657
dc.identifier.urihttp://hdl.handle.net/10019.1/13579
dc.subjectabciximab
dc.subjectacetylsalicylic acid
dc.subjectamiloride
dc.subjectangiopeptin
dc.subjectanticoagulant agent
dc.subjectantisense oligonucleotide
dc.subjectarginine
dc.subjectbeta adrenergic receptor blocking agent
dc.subjectcarvedilol
dc.subjectcilazapril
dc.subjectcorticosteroid
dc.subjectcyclosporin A
dc.subjectdiltiazem
dc.subjectdipyridamole
dc.subjecteptifibatide
dc.subjectfish oil
dc.subjectheparin
dc.subjecthirudin
dc.subjecthirulog
dc.subjectketanserin
dc.subjectlosartan
dc.subjectlow molecular weight heparin
dc.subjectmevinolin
dc.subjectmonoclonal antibody
dc.subjectprobucol
dc.subjectprostacyclin
dc.subjectsulfinpyrazone
dc.subjecttrapidil
dc.subjecturokinase
dc.subjectcoronary artery obstruction
dc.subjectendothelium
dc.subjecthuman
dc.subjectintraarterial drug administration
dc.subjectpathogenesis
dc.subjectreview
dc.subjectthrombosis
dc.subjecttransluminal coronary angioplasty
dc.titleRestenosis after coronary angioplasty - A review of the pathogenesis and strategies for prevention
dc.typeReview
Files